Ignite Creation Date:
2025-12-24 @ 3:28 PM
Ignite Modification Date:
2025-12-28 @ 4:12 AM
Study NCT ID:
NCT03183492
Status:
WITHDRAWN
Last Update Posted:
2018-03-02
First Post:
2017-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-01-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-01-28
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-30
First Submit QC Date:
None
Study First Post Date:
2017-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-01
Last Update Post Date:
2018-03-02
Last Update Post Date Type:
ACTUAL